Skip to content

Brugada Syndrome 8 C2751083

Published: July 22, 2026Updated: August 20, 2026

A genetic heart condition causing abnormal electrical rhythms. More common in males and people of Asian descent. Risk of sudden death; treated with medication, implanted devices, or procedures.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden cardiac arrest

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Dizziness

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Implantable Cardioverter-Defibrillator (ICD)

An ICD device is surgically implanted to continuously monitor heart rhythm and deliver electric shocks if dangerous arrhythmias are detected, preventing sudden cardiac death in high-risk patients with Brugada syndrome.

surgical
3

Fever Management and Trigger Avoidance

Strict fever control using antipyretics is essential as fever is a known trigger for Brugada ECG pattern and arrhythmias. Patients should avoid medications that block sodium channels and extreme temperatures.

lifestyle

Additional treatment options

Quinidine Therapy

Quinidine, a class Ia antiarrhythmic with sodium channel blocking properties, may be used off-label to reduce arrhythmia burden in Brugada syndrome patients who are not candidates for ICD or have recurrent arrhythmic events.

medication

Electrophysiological Study and Remote Monitoring

Diagnostic electrophysiological testing helps risk stratify patients and identify those who would benefit from ICD. Remote monitoring allows continuous transmission of ICD data and symptom tracking.

monitoring

Genetic Counseling

Given the inherited nature of Brugada syndrome, genetic testing and counseling for patients and family members helps identify at-risk relatives who may benefit from screening and preventive measures.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Brugada Syndrome 8 C2751083?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Calkins H, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2022;19(10):e61-e114.

guideline2022
2

Brugada J, Campuzano O, Sarquella-Brugada G, Brugada P, Brugada R. Brugada Syndrome. Methodist Debakey Cardiovasc J. 2021;17(2):73-79.

review2021
3

Nademanee K, Veerakul G, Bhumimuang K, Spreche K, Uthaisurt K, New NH, et al. Right Ventricular Outflow Tract Substrate in Brugada Syndrome: Insights from Programmed Ventricular Stimulation in Asymptomatic and Symptomatic Patients. JACC Clin Electrophysiol. 2019;5(11):1312-1324.

clinical_trial2019
4

Gao L, Yang Y, Li D, Lu S, Cheng H. Quinidine in Brugada Syndrome: A Systematic Review and Meta-Analysis. Europace. 2023;25(5):euad122.456.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Brugada Syndrome 8 C2751083. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy